太美医疗科技（股票代码：02576）于2026年10月2日公告，披露公司当天于香港联交所回购普通股H股共2万股，占回购前现有已发行股份约0.01%。本次回购的每股价格介乎每股港币4.54元至4.75元，合计支付约港币9.36万元。
回购完成后，公司现有已发行股份总数为200,592,533股，其中193,227,733股为已发行流通股，7,364,800股作为库藏股。本次回购根据2026年6月23日通过的回购授权进行，授权最高可回购20,017,153股。截至目前，公司共计回购6,943,800股，占回购授权通过当日已发行股份总数约3.47%。
公司在公告中表示，本次股份购回严格遵守相关上市规则及相关法律法规，公告由执行董事及联席公司秘书倪晓梅签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.